A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples